alerian oot - American Herbal Pharmacopoeia

R. 1986. Bacterial mutagenicity of the
tranquilizing constituents of
Valerianaceae roots. Mut Res 169:23-7.
Johnson R, Waller G. 1971. Isolation of
actinidine from Valeriana officinalis.
Phytochem Rep 10:3334-5.
Kamm-Kohl AV, Jansen W, Brockmann P.
1984. Modern valerian therapy of nervous
disorders in elderly patients.
Medwelt 35:1450-4.
Keochanthala-Bounthanh C, Haag-
Berrurier M, Beck JP, Anton R. 1990.
Effects of thiol compounds versus
cytotoxicity of valepotriates on cultured
hepatoma cells. Planta Med
56:190-2.
Keochanthala-Bounthanh C, Haag-
Berrurier M, Beck JP, Anton R. 1993.
Effects of two monoterpene esters, valtrate
and didrovaltrate, isolated from
Valeriana wallichi, on the ultrastructure
of hepatoma cells in culture.
Phytother Res 7:124-7.
King J. 1866. The American Dispensatory.
7th ed. Cincinnati: Moore, Wilstach
& Baldwin. 1509 p.
Kohnen R, Oswald WD. 1988. The effects
of valerian, propranolol and their combination
on activation, performance
and mood of healthy volunteers under
social stress conditions.
Pharmacopsychiatry 21:447-8.
Krieglstein J, Grusla D. 1988. Central
depressant constituents in Valeriana,
valepotriate, valerenic acid, valeranone
and volatile oil are ineffective afterall.
Dtsch Apoth Ztg 128:2041-6.
Leathwood PD, Chauffard F. 1982/3.
Quantifying the effects of mild sedatives.
J Psychiat Res 17(2):115-22.
Leathwood PD, Chauffard F. 1985.
Aqueous extract of valerian reduces
latency to fall asleep in man. Planta
Med 51:144-8.
Leathwood PD, Chauffard F, Heck E,
Munoz-Box R. 1982. Aqueous extract
of valerian root, (Valeriana officinalis
L) improves sleep quality in man.
Pharmacol Biochem Behav 17:65-71.
Leung A, Foster S. 1996. Encyclopedia of
Common Natural Ingredients Used in
Food, Drugs and Cosmetics. New
York: J Wiley. 649 p.
Leuschner J, Müller J, Rudmann M. 1993.
Characterization of the central nervous
depressant activity of a commercially
available valerian root extract.
Arzneim Forsch Drug Res 43 Suppl
1(6):638-44.
Long C. 1987. The chemical constituents
of the essential oil from the roots of
Valeriana officinalis var latifolia.
Yunnan Zhiwu Yanjiu 9(1):109-12.
Lutowski J, Turowska M. 1973. Effect of
relative humidity on the content of
valepotriates and volatile oil in
Valeriana officinalis. Herba Pol
19(4):338-41.
MacGregor FGB, Abernethy VE, Dahara
S. 1989. Hepatotoxicity of herbal
remedies. BMJ 299:1156-7.
Marekov NL, Popov SS, Handjieva NV.
1983. Chemistry of pharmaceutically
important cyclomonoterpenes from
some Valeriana plants. Proceedings of
the 2nd International Conference
Budapest. Amsterdam: Elsevier
Science. p 313-41.
McGuffin M, Hobbs C, Upton R,
Goldberg A. 1997. Botanical Safety
Handbook. Boca Raton (FL): CRC.
231 p.
Mennini T, Bernasconi P, Bombardelli E,
Morazzoni P. 1993. In vitro study on
the interaction of extracts and pure
compounds from Valeriana officinalis
roots with GABA, benzodiazepine and
barbiturate receptors in rat brain.
Fitoterapia 44(4):291-300.
Mheen HJ. 1996. Crop management
research on root-crop-herbs (Angelica,
Levisticum and Valeriana).
Horticulture 271.
Morazzoni P, Bombardelli E. 1995.
Valeriana officinalis: traditional use
and recent evaluation of activity.
Fitoterapia 66(2):99-112.
Osol A, Farrar GE, Leuallen EE,
Youngken HW, Verwey WF, Detweiler
DK. 1947. The Dispensatory of the
United States of America. 24th ed.
Philadelphia: JB Lippincott. 1928 p.
Österreichisches Arzneibuch. 1990. Radix
Valerianae Baldrianwurzel. Volume 1.
Wien: Verlag der Österreichischen
Staatsdruckerei.
Petkov V. 1979. Plants with hypotensive,
antiatheromatous and coronary dilating
action. Am J Chin Med VII 3:216-
8.
Pharmacopée Française. 1987. Valeriana
officinalis for Homeopathic
Preparations. 10th ed. Paris: La
Commission Nationale de
Pharmacopée.
Pharmacopeial Forum. 1998. Valerian.
Volume 24(5). Rockville (MD): US
Pharmacopeial Convention.
Pharmacopoea Helvetica 8. 1997.
Valerianae radix. Bern:
Eidgenössisches Dep des Innern.
Pharmacopoea Italica. 1991. Farmacopea
Ufficiale della Repubblica Italiana.
Roma: Ist Poligrafico Zecca Stato PV.
333 p.
Pickering C. 1879. Chronological History
of Plants. Boston: Little, Brown. 518 p.
Reynolds J, editor(s). 1993. Martindale
The Extra Pharmacopoeia. 30th ed.
London: Pharm Pr. 2363 p.
Riedel E, Hänsel R, Ehrke G. 1982.
Inhibition of gamma-aminobutyric
acid catabolism by valerenic acid
derivatives. Planta Med 46:219-20.
Rosecrans JA, Defeo JJ, Youngken Jr HW.
1961. Pharmacological investigation of
certain Valeriana officinalis L extracts.
J Pharm Sci 50(3):240-4.
Rücker G, Tautges J, Sieck A, Wenzl H,
Graf E. 1978. Untersuchungen zur
isolierung und pharmakodynamischen
aktivität des sesquiterpens Valeranon
aus Nardostachys jatamansi DC.
Arzneim Forsch Drug Res 28(1):7.
Sakamoto T, Mitani Y, Nakajima K. 1992.
Psychotropic effects of Japanese valerian
root extract. Chem Pharm Bull
40:758-61.
Samuelsson G. 1992. Drugs of Natural
Origin: A Textbook of Pharmacognosy.
Stockholm: Swedish Pharm Pr. 320 p.
Santos MS, Ferreira F, Cunha AP,
Carvalho AP, Macedo T. 1994a. An
aqueous extract of valerian influences
the transport of GABA in synaptosomes.
Planta Med 60:278-9.
Santos MS, Ferreira F, Faro C, Pires E,
Carvalho AP, Cunha AP, Macedo T.
1994b. The amount of GABA present
in aqueous extracts of valerian is sufficient
to account for (3H)GABA
release in synaptosomes. Planta Med
60:475-6.
Scudder JM. 1903. Specific Medications
and Specific Medicines. 15th ed.
Cincinnati: Scudder Bros. 432 p.
Reprinted: 1985.
Seifert T. 1988. Therapeutische Effekte
von Baldrian bei nervösen Störungen.
Klinik Praxis Therapie 2:94-8.
Shaw D, Leon C, Kolev S, Murray V.
1997. Traditional remedies and food
supplements: a 5-year toxicological
study (1991-1995). Drug Safety 5:342-
56.
Skramlik VEV. 1959. Über die Giftigkeit
und Verträglichkeit von ätherischen
Ölen. Pharmazie 14:435-45.
Stahl E, Schild W. 1971. Über die
Verbreitung der äquilibrierend wirkenden
valepotriate in der familie der
Valerianaceae. Phytochemistry 10:147-
53.
Steinegger E, Hänsel R. 1992. Textbook of
Pharmacognosy and
Phytopharmacology. 4th ed. Berlin:
Springer-Verlag. 804 p.
Stillé A, Maisch J, Caspari C, Maisch H.
1896. The National Dispensatory
Containing the Natural History,
Chemistry, Pharmacy, Actions and
Uses of Medicines. 5th ed.
Philadelphia: Lea Bros. 1903 p.
Titz W, Jurenitsch J, Fitzbauer-Busch E,
Wicho E, Kubelka W. 1982.
Valepotriate und ätherisches Öl morphologisch
und chromosomal
definierter typen von Valeriana officinalis
s.l.. Sci Pharm 50:309-24.
Titz W, Jurenitsch J, Gruber J, Schabaus I,
Titz E, Kubelka W. 1983. Valepotriate
und ätherische Öl, morphologisch
und chromosomal definierter typen
von Valeriana officinalis L II
Variationen charakteristischer komponenten
der ätherischen Öles. Sci
Pharm 51:63-86.
Torssell K, Wahlberg K. 1967. Isolation
structure and synthesis of alkaloids
from Valeriana officinalis L. Acta
Chem Scandinav 21:53-62.
Tufik S, Fujita K, de Lourdes V, Seabra
M, Lobo LL. 1994. Effects of a pro-
longed administration of valepotriates
in rats on the mothers and their offspring.
J Ethnopharmac 41:39-44.
Valnet J. 1992. Phytotherapie: Treatment
des Maladies Par Les Plantes. 6th ed.
Paris: Maloine Pr.
Violon C, Cauwenbergh N, Vercruysse A.
1983. Valepotriate content in different
in vitro cultures of Valerianaceae and
characterization of Valerianaceae officinalis
L callus during a growth period.
Pharm Weekbl 5:205-9.
Violon C, Sonck W, Vercruysse A. 1984.
Comparative study of the essential oils
of in vivo and in vitro grown Valeriana
officinalis L and Centranthus
macrosiphon Boiss by coupled gas
chromatography-mass spectrometry. J
Chromatog 288:474-8.
Voight-Schmidt J. 1986. Treatment of nervous
sleep disturbances and inner restlessness
with a purely herbal sedative:
results of a study in general practice.
Therapiewoche 36:663-7.
Wagner H, Jurcic K. 1980. In vitro and in
vivo metabolismus von 14 C-didrovaltrat.
Planta Med 38:366-76.
Wagner H, Schaette R, Hörhammer L,
Hölzl J. 1972. On the dependence of
the valepotriate and ethereal oil content
in Valeriana officinalis L sl upon
different exogenous and endogenous
factors. Arzneim Forsch Drug Res
22(7):1204-9.
Weiss RF. 1988. Herbal Medicine. Meuss
AR, translator. 6th ed. Beaconsfield:
Beaconsfield Publishing. 362 p.
Translation of: Lehrbuch der
Phytotherapie.
Wichtl M, Bisset NG, editor(s). 1994.
Herbal Drugs and
Phytopharmaceuticals. Stuttgart:
Medpharm Science. 566 p.
Willey L, Mady S, Cobaugh D, Wax P.
1995. Valerian overdose: a case report.
Vet Human Toxicol 37(4):364-5.
Woerdenbag HJ, Bos R, Scheffer JJ.
Valerian The Genus Valeriana. 1997.
Houghton PJ, editor(s). London:
Harwood Acad Publishers. 142 p.
Wood GB, Bache F. 1849. The
Dispensatory of the United States of
America. 8th ed. Philadelphia: Grigg,
Elliot. 1380 p.
Woodville W. 1810. Medical Botany.
Volume 1. 2nd ed. London: William
Phillips. 188 p.
Youngken HW. 1930. A Textbook of
Pharmacognosy. 3rd ed. Philadelphia:
P Blakiston’s. 817 p.
American Herbal Pharmacopoeia • Valerian Root • April 1999 Page 25